High Growth Potential for Carotid Stent and Thoracic Aortic Stent Gra...(to greater than 20% before2012. Our ...),Health

"Our market forecasts present variable growth models," says Stephanie LaBelle, Analyst at Millennium Research Group. "These models consider the potential expansion of carotid stenting reimbursement, the completion of CREST, a large randomized clinical study comparing the efficacy of carotid artery stenting versus carotid endarterectomy, and the release of post-market carotid stenting surveillance data. These forecasts are supported by a survey of US physicians who rated expanded CMS reimbursement as the factor that would have the largest impact on growth in carotid stenting procedures; the release of clinical trial data supporting carotid artery stenting was rated second-most important."

The US Markets for Peripheral Vascular Devices 2008 report provides coverage of all key industry competitors, including Abbott Vascular, AngioDynamics, B. Braun, Boston Scientific, Cook Medical, Cordis, C. R. Bard, ev3, Medtronic, W. L. Gore, and Terumo, among others. Global coverage of this report includes Europe, Asia-Pacific, Latin America, Canada, and Japan.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group